Identification, characterization, and localization of the dopamine D3 receptor in rat brain using 7-[3H]hydroxy-N,N-di-n-propyl-2-aminotetralin
about
Alcoholism: A Systems Approach From Molecular Physiology to Addictive BehaviorAlterations in postnatal neurogenesis and dopamine dysregulation in schizophrenia: a hypothesisLack of abuse potential in a highly selective dopamine D3 agonist, PF-592,379, in drug self-administration and drug discrimination in ratsAntagonism of the effects of (+)-PD 128907 on midbrain dopamine neurones in rat brain slices by a selective D2 receptor antagonist L-741,626.The neural and genetic basis of executive function: attention, cognitive flexibility, and response inhibition.Neuropsychopharmacology and neurogenetic aspects of executive functioning: should reward gene polymorphisms constitute a diagnostic tool to identify individuals at risk for impaired judgment?Blonanserin ameliorates phencyclidine-induced visual-recognition memory deficits: the complex mechanism of blonanserin action involving D₃-5-HT₂A and D₁-NMDA receptors in the mPFC.Stereochemical and neuroanatomical selectivity of pramipexole effects on sensorimotor gating in ratsHow do the atypical antipsychotics work?A paradoxical regulation of the dopamine D3 receptor expression suggests the involvement of an anterograde factor from dopamine neuronsDopamine receptor activation promotes adult neurogenesis in an acute Parkinson modelBeyond small-molecule SAR: using the dopamine D3 receptor crystal structure to guide drug designDifferential Effect of the Dopamine D3 Agonist (±)-7-Hydroxy-2-(N,N-di-n-propylamino) Tetralin (7-OH-DPAT) on Motor Activity between Adult Wistar and Sprague-Dawley Rats after a Neonatal Ventral Hippocampus Lesion.Phenylpiperazine derivatives with selectivity for dopamine D3 receptors modulate cocaine self-administration in ratsDifferential effect of quinpirole and 7-OH-DPAT on the spontaneous [(3)H]-dopamine efflux from rat striatal synaptosomes.A series of 18F-labelled pyridinylphenyl amides as subtype-selective radioligands for the dopamine D3 receptor.Dopamine transporter trafficking: rapid response on demand.In vitro and in vivo evaluation of the binding of the dopamine D2 receptor agonist (11)C-(R,S)-5-hydroxy-2-(di-n-propylamino)tetralin in rodents and nonhuman primate.A functional fast scan cyclic voltammetry assay to characterize dopamine D2 and D3 autoreceptors in the mouse striatum.Dopamine agonist-induced yawning in rats: a dopamine D3 receptor-mediated behavior.The dopamine D3 receptor partial agonist CJB090 and antagonist PG01037 decrease progressive ratio responding for methamphetamine in rats with extended-access.Levo-tetrahydropalmatine attenuates cocaine self-administration under a progressive-ratio schedule and cocaine discrimination in ratsEating high-fat chow increases the sensitivity of rats to quinpirole-induced discriminative stimulus effects and yawning.In vitro reinforcement of hippocampal bursting: a search for Skinner's atoms of behaviorPathophysiology of levodopa-induced dyskinesia: potential for new therapies.Acute administration of SB-277011A, NGB 2904, or BP 897 inhibits cocaine cue-induced reinstatement of drug-seeking behavior in rats: role of dopamine D3 receptors.The D3 dopamine receptor and substance dependence.Dopamine D1, D2, D3 receptors, vesicular monoamine transporter type-2 (VMAT2) and dopamine transporter (DAT) densities in aged human brain.Dopamine D3 receptors in the basolateral amygdala and the lateral habenula modulate cue-induced reinstatement of nicotine seeking.The antipsychotics olanzapine, risperidone, clozapine, and haloperidol are D2-selective ex vivo but not in vitro.Stimulation of dopamine D2/D3 but not D1 receptors in the central amygdala decreases cocaine-seeking behaviorDrug dependence: neuropharmacology and management.Yawning and hypothermia in rats: effects of dopamine D3 and D2 agonists and antagonists.Behavioral sensitization to cocaine in rats: evidence for temporal differences in dopamine D3 and D2 receptor sensitivityThird generation antipsychotic drugs: partial agonism or receptor functional selectivity?Effect of loxapine on peripheral dopamine-like and serotonin receptors in patients with schizophrenia.Effects of selective dopaminergic compounds on a delay-discounting task.Neuropharmacology of dopamine receptors:: Implications in neuropsychiatric diseasesSex mediates dopamine and adrenergic receptor expression in adult rats exposed prenatally to cocaine.Drinking sucrose enhances quinpirole-induced yawning in rats.
P2860
Q22241964-61EB7FB2-9594-47B6-87AD-336B973BE942Q24606423-579F0CB9-6163-4416-AFCF-03914E22DFFEQ24614563-249EA89A-312F-442B-91C3-E96F8B4FBBE2Q24674289-DD5343BF-7B7B-4075-85CA-A72BB84D3044Q27013979-9A6D4637-6F4D-44EB-B649-EEEDC4803CF0Q27024858-8C24C1D0-EDE3-4D10-AD62-B8A0F8B560F5Q27311205-434CB07F-B400-4DF0-A9C8-0DFA59CE10A6Q28256971-BE3618DD-0E2E-415F-9642-F2438C79C3DFQ28344179-C2FE136F-D4E5-42F7-8734-24939B5EA58FQ28368794-1F55E5FA-3496-4FC9-B067-13D068FF0399Q28579481-4495B0DF-AFEE-44E2-B76E-CD026AD0154CQ28828620-FB9DFA15-3616-4177-B7FC-599DFB1A42A2Q30412496-1C9EBFE2-8054-4946-A4F0-62B06711120DQ30581703-760217C4-A00F-40E1-8F3E-063856214366Q31913355-3B9498DE-950C-4ACE-807D-5184CD058D39Q33560926-06B157AA-F44B-4930-BFDC-7CDAC69AA33FQ33654916-5D94E43A-7E4E-4F63-B92B-CF81C34BD82EQ33904670-DA7066C6-4D8A-43C9-BDEA-498E1A4F8040Q33921257-73899721-90CB-4E74-B6DD-4728582CB38AQ33947433-380D6D97-37FA-4EF1-BC7E-DB5A8C64B578Q33992366-EFF66E96-9299-4B57-9D7B-A3065272B352Q34209414-B3C5C3F6-8C08-4BFD-9124-BB4D3D4C787BQ34241047-98472DDA-6B95-4E54-A6D1-7803CF06B5C1Q34270042-17963D47-41B4-4211-8BFC-21D1DDE6BD2CQ34325365-F41CF5C4-6107-453D-9A35-BD740A15E349Q34414507-95EA789D-44A1-4998-A66A-5A3044BAE3C7Q34420270-61361997-5A9A-4C59-AD65-1093CD4BF027Q34490087-4F77674F-4B17-4E93-A25C-5E30964FE898Q34499327-950497E0-6E2C-4B0A-9964-FC5647D97917Q34661099-DB62707C-FD32-4E4F-A516-C358065453ADQ34768667-73C6DACC-B7D0-4DF1-B0D0-3E0F82EB9DF6Q34773986-E5654309-4A7E-4D63-A843-E7D40B8AF6CFQ34982537-D6CEB4E1-93DF-42CE-90AC-FC1A1668D599Q35009583-9A918D44-6CA6-4BE2-9F6E-D9A7460E9C0BQ35012574-E3A0BE0C-D011-43D5-80A3-C5F15410D998Q35101377-5F5ED723-5F0A-4581-AB6F-A03A37455778Q35103242-6A7F9807-8289-479B-9CB6-0355FCA5889EQ35217260-B32C0197-9E0E-4DEC-8198-D7F57561AF87Q35254008-7B5C005F-949F-48B4-B29D-B579E02AA6DFQ35539794-4A03F536-90C1-4D2E-B071-5C562DBD5D53
P2860
Identification, characterization, and localization of the dopamine D3 receptor in rat brain using 7-[3H]hydroxy-N,N-di-n-propyl-2-aminotetralin
description
1992 nî lūn-bûn
@nan
1992 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
name
Identification, characterizati ...... ,N-di-n-propyl-2-aminotetralin
@ast
Identification, characterizati ...... ,N-di-n-propyl-2-aminotetralin
@en
Identification, characterizati ...... ,N-di-n-propyl-2-aminotetralin
@nl
type
label
Identification, characterizati ...... ,N-di-n-propyl-2-aminotetralin
@ast
Identification, characterizati ...... ,N-di-n-propyl-2-aminotetralin
@en
Identification, characterizati ...... ,N-di-n-propyl-2-aminotetralin
@nl
prefLabel
Identification, characterizati ...... ,N-di-n-propyl-2-aminotetralin
@ast
Identification, characterizati ...... ,N-di-n-propyl-2-aminotetralin
@en
Identification, characterizati ...... ,N-di-n-propyl-2-aminotetralin
@nl
P2093
P2860
P356
P1476
Identification, characterizati ...... ,N-di-n-propyl-2-aminotetralin
@en
P2093
D Lévesque
J C Schwartz
J L Morgat
M P Martres
P Sokoloff
P2860
P304
P356
10.1073/PNAS.89.17.8155
P407
P577
1992-09-01T00:00:00Z